U.S. Markets open in 45 hrs, 29 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,451.19 | -128.00 | -1.49% |
| NASDAQ | 1,649.51 | 4.39 | 0.27% |
| S&P 500 | 899.22 | -10.70 | -1.18% |
| Day Low 01:59 PM EDT | 1.68 | |
|---|---|---|
| Day High 03:48 PM EDT | 2.29 |
|
| Range | 0.61 | |
| Volume | 897,189 | |
| 30-Day Avg. Vol. | 460,000 |
|
| Difference | 95.04% | |
| Market Cap. | 112.67 M | |
| Change | -11.88 M | |
| Shares Out. | 56.61 M | |
| Percent Traded | 1.58% | |
| Revenue (LFY) | 48.66 M | |
| Earnings (TTM) | -63.74 M | |
| Next Earnings | 11/07/2008 |
|
| EPS (TTM) | -1.42 |
| 52-Wk Low 10/10/08 | 1.68 | |
|---|---|---|
| 52-Wk High 10/23/07 | 7.27 |
|
| Range | 5.59 | |
| Prev. Close 10/9/08 | 2.20 | |
| Today's Open | 2.05 | |
| Change | -6.82% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 1.0858 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | — |
Inspire Pharmaceuticals doesn't want to leave a dry eye in the house. The company targets treatments for various respiratory and ocular diseases caused by malfunctioning P2 receptors, which regulate the ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.317 3/31/08 | -0.46 3/31/08 |
-0.143
Missed
|
| Last Quarter | -0.24 6/30/08 | -0.11 6/30/08 |
0.13
Beat
|
| Quarterly - 06/30/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 21.98 M | 48.66 M |
| Gross Profit | 20.34 M | 44.37 M |
| Operating Income | -5.88 M | -65.88 M |
| Net Income | -6.36 M | -63.74 M |
